Latest Articles
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - EMJ | Elevating the quality of healthcare globally
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk EMJ | Elevating the quality of healthcare globally
Published: Feb. 18, 2026, noon
This surgery could slash the risk of the deadliest female cancer by almost 80% - SMH.com.au
This surgery could slash the risk of the deadliest female cancer by almost 80% SMH.com.au
Published: Feb. 18, 2026, 8 a.m.
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... - Medical Dialogues
Adding GLP-1RA to Progestin Therapy may reduce Endometrial Cancer Risk among women with benign uterine... Medical Dialogues
Published: Feb. 17, 2026, 3:15 p.m.
Taskmaster star Fatiha El-Ghorri opens up about cancer treatment - AOL.com
Taskmaster star Fatiha El-Ghorri opens up about cancer treatment AOL.com
Published: Feb. 17, 2026, 8:09 a.m.
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Published: Feb. 17, 2026, 12:15 a.m.
Comedian Fatiha El-Ghorri, 44, has been through a hysterectomy after being diagnosed with endometrial cancer - UrbanMatter
Comedian Fatiha El-Ghorri, 44, has been through a hysterectomy after being diagnosed with endometrial cancer UrbanMatter
Published: Feb. 16, 2026, 9:11 p.m.
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer - Daily Mail
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer Daily Mail
Published: Feb. 16, 2026, 1:01 p.m.
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer - dailymail.co.uk
Comedian Fatiha El-Ghorri, 44, reveals she has undergone a hysterectomy after being diagnosed with endometrial cancer dailymail.co.uk
Published: Feb. 16, 2026, 1:01 p.m.
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients - geneonline.com
Eli Lilly Builds $1.5 Billion Stockpile of Oral GLP-1 Drug as Study Shows 66% Drop in Endometrial Cancer Risk for Certain Patients geneonline.com
Published: Feb. 16, 2026, 10:55 a.m.
Pharma Pulse: The $1.5 Billion Weight Management Gamble and a Cancer Prevention Breakthrough - Pharmaceutical Commerce
Pharma Pulse: The $1.5 Billion Weight Management Gamble and a Cancer Prevention Breakthrough Pharmaceutical Commerce
Published: Feb. 16, 2026, 10:47 a.m.
Link copied to clipboard!